USFDA issues warning letter to ex-Sun Pharma US facility Industry-The Economic Times — August 26, 2016 comments off The Philadelphia plant is among the two facilities that Sun Pharma had sold to Frontida BioPharm in June this year, along with 15 products, for an undisclosed amount.
